CAS NO: | 476-28-8 |
包装 | 价格(元) |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Lycorine is a natural alkaloid extracted from theAmaryllidaceaeplant. Lycorine is a potent and orally activeSCAPinhibitor with aKdvalue 15.24 nM. Lycorine downregulates the SCAP protein level without changing its transcription[2]. Lycorine is also amelanoma vasculogenicinhibitor[3]. Lycorine can be used for the study of prostatecancerand metabolic diseases[2]. | ||||||||||||||||||||||||
IC50& Target | Kd: 15.24 nM (SCAP)[1] | ||||||||||||||||||||||||
体外研究 (In Vitro) | Lycorine inhibits cell proliferation in a dose-dependent manner in the abovementioned 4 PCa cell lines, and the IC50ranged from 5 μM to 10 μM., it also shows Lycorine has little effects on PNT1A cell's proliferation[1].SCAP (SREBF chaperone) is an ER-toGolgi transport protein, undergoes a conformational change, and regulates/preserves SREBFs in the ER by forming a complex with INSIG1 (insulin induced gene 1)[2].Lycorine (5-40 μM; 16 hours) significantly suppresses SREBFs activity (up to -70%) in a dosedependent manner and does not cause obvious cytotoxicity in cells[2].Lycorine (10-20 μM; 2-16 hours) dose- and time-dependently decreases the mature SREBF1 and SREBF2 proteins in HL-7702 cells[2].Lycorine (20 μM; 16 hours) neither activates NR1H3 transcription nor affect NR1H3 target genes, including ABCG5 and ABCG8, but Sterols activates NR1H3 transcription activity[1].Lycorine hydrochloride (0-25 μM; 48 hours) treatment markedly suppresses the expression of vascular endothelial (VE)-cadherin in a dose-dependent manner and also slightly diminishes the expression of Sema4D in C8161 cells. However, the expression of the other six genes is not affected[3].Lycorine hydrochloride (0-25 μM; 48 hours) treatment markedly reduces VE-cadherin protein levels in C8161 cells in a dose-dependent fashion[3]. Cell Viability Assay[2]
Western Blot Analysis[2]
RT-PCR[3]
| ||||||||||||||||||||||||
体内研究 (In Vivo) | Lycorine (oral chow; 15 mg/kg, 30 mg/kg; once daily) alleviates fat accumulation and metabolic syndrome, increases lipolysis and betaoxidation of fatty acid along with precursor and mature SREBFs in mice[2].
| ||||||||||||||||||||||||
分子量 | 287.31 | ||||||||||||||||||||||||
性状 | Solid | ||||||||||||||||||||||||
Formula | C16H17NO4 | ||||||||||||||||||||||||
CAS 号 | 476-28-8 | ||||||||||||||||||||||||
中文名称 | 石蒜碱 | ||||||||||||||||||||||||
结构分类 |
| ||||||||||||||||||||||||
来源 |
| ||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
储存方式 |
| ||||||||||||||||||||||||
溶解性数据 | In Vitro: DMSO : 25 mg/mL(87.01 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |